跳转至内容
Merck
CN

Neonatal hyperbilirubinemia--an update for South Dakota physicians.

South Dakota medicine : the journal of the South Dakota State Medical Association (2015-02-03)
Stacy Kern, Suzanne Reuter
摘要

Most newborn infants develop hyperbilirubinemia in the neonatal period. Excessive levels of hyperbilirubinemia places the infant at risk for bilirubin encephalopathy. We discuss the metabolism of bilirubin and the most likely etiologies for elevated bilirubin levels in the newborn. We describe methods to evaluate bilirubin levels and the formal hyperbilirubinemia risk assessment each infant deserves prior to discharge from the nursery. In addition, we review management of infants with hyperbilirubinemia, including phototherapy, intravenous immunoglobulin and exchange transfusion.

材料
Product Number
品牌
产品描述

Sigma-Aldrich
胆红素, ≥98% (EmM/453 = 60), powder
Sigma-Aldrich
胆红素, purum, ≥95.0% (UV)